European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and "harm reduction"

Eur Respir J. 2024 Feb 22;63(2):2301808. doi: 10.1183/13993003.01808-2023. Print 2024 Feb.

Authors

Daniel Tzu-Hsuan Chen¹, Jonathan Grigg², Filippos T Filippidis³; Tobacco Control Committee of the European Respiratory Society

Affiliations

¹ Nuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK daniel.chen@phc.ox.ac.uk.
² Centre for Child Health, Blizard Institute, Queen Mary University of London, London, UK.
³ Public Health Policy Evaluation Unit, School of Public Health, Imperial College London, London, UK.

PMID: 38316440
DOI: 10.1183/13993003.01808-2023

No abstract available

Publication types

Editorial

MeSH terms

Humans
Nicotine* / adverse effects
Smoking
Tobacco Control
Tobacco Products* / adverse effects

Substances

Nicotine